ASX:BIT

Biotron Competitors

Add

Compare

Today's Range N/A

50-Day Range

A$0.09

MA: A$0.09▼

A$0.09

52-Week Range N/A

Volume1.03 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Biotron (ASX:BIT) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying BIT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Biotron, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Biotron vs. (CHV) Stock

(CHV) (CNSX:CHV) and Biotron (ASX:BIT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (CHV) and Biotron, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Biotron	0	0	0	0	N/A

Profitability

This table compares (CHV) and Biotron's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Biotron	N/A	N/A	N/A

Valuation and Earnings

This table compares (CHV) and Biotron's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A

(CHV) has higher earnings, but lower revenue than Biotron.

Summary

Biotron beats (CHV) on 1 of the 1 factors compared between the two stocks.

Biotron vs. (DDXS) Stock

(DDXS) (OTCMKTS:DDXS) and Biotron (ASX:BIT) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares (DDXS) and Biotron's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A

(DDXS) has higher earnings, but lower revenue than Biotron.

Profitability

This table compares (DDXS) and Biotron's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Biotron	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for (DDXS) and Biotron, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Biotron	0	0	0	0	N/A

Summary

Biotron beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Biotron vs. (PREV) Stock

(PREV) (CNSX:PREV) and Biotron (ASX:BIT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Profitability

This table compares (PREV) and Biotron's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Biotron	N/A	N/A	N/A

Valuation and Earnings

This table compares (PREV) and Biotron's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A

(PREV) has higher earnings, but lower revenue than Biotron.

Analyst Ratings

This is a breakdown of current ratings and target prices for (PREV) and Biotron, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Biotron	0	0	0	0	N/A

Summary

Biotron beats (PREV) on 1 of the 1 factors compared between the two stocks.

Biotron vs. (TNGN) Stock

Biotron (ASX:BIT) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, profitability, institutional ownership, dividends and risk.

Profitability

This table compares Biotron and (TNGN)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotron	N/A	N/A	N/A
(TNGN)	N/A	N/A	N/A

Valuation & Earnings

This table compares Biotron and (TNGN)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A
(TNGN)	N/A	N/A	N/A	N/A	N/A

(TNGN) has lower revenue, but higher earnings than Biotron.

Analyst Recommendations

This is a summary of current recommendations and price targets for Biotron and (TNGN), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotron	0	0	0	0	N/A
(TNGN)	0	0	0	0	N/A

Summary

Biotron beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Biotron vs. 138267 (COM.TO) Stock

138267 (COM.TO) (TSE:COM) and Biotron (ASX:BIT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for 138267 (COM.TO) and Biotron, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
138267 (COM.TO)	0	0	0	0	N/A
Biotron	0	0	0	0	N/A

Profitability

This table compares 138267 (COM.TO) and Biotron's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
138267 (COM.TO)	N/A	N/A	N/A
Biotron	N/A	N/A	N/A

Valuation and Earnings

This table compares 138267 (COM.TO) and Biotron's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A

138267 (COM.TO) has higher earnings, but lower revenue than Biotron.

Summary

Biotron beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Biotron vs. 17031 Stock

17031 (CNSX:MYM) and Biotron (ASX:BIT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for 17031 and Biotron, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
17031	0	0	0	0	N/A
Biotron	0	0	0	0	N/A

Valuation and Earnings

This table compares 17031 and Biotron's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
17031	N/A	N/A	N/A	N/A	N/A
Biotron	$853,026.00	0.00	$-4,211,597.95	A($0.01)	N/A

17031 has higher earnings, but lower revenue than Biotron.

Profitability

This table compares 17031 and Biotron's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
17031	N/A	N/A	N/A
Biotron	N/A	N/A	N/A

Summary

Biotron beats 17031 on 1 of the 1 factors compared between the two stocks.